Status:
RECRUITING
Identification of New Biomarkers for the Prediction of Cardiovascular Events
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Cardiovascular Diseases
Eligibility:
All Genders
18-99 years
Brief Summary
The main goal of this project is to constitute a collection of biological samples, obtained through the clinical activity of the Centre for Screening and Prevention of Atherosclerosis at Toulouse Univ...
Detailed Description
Cardiovascular (CV) diseases, particularly those secondary to atherosclerosis, are a leading cause of morbidity and mortality in modern societies. Classical CV risk factors, including age and gender, ...
Eligibility Criteria
Inclusion
- Adults over 18 yrs;
- consulting the Centre for Screening and Prevention of Atherosclerosis (CDPA) for management of their cardiovascular risk factors;
- patients on primary prevention, free of personal history of coronary artery disease, stroke or lower limb arteriopathy, or patients on secondary prevention having presented one of the above mentioned diseases;
- patients affiliated to a health insurance system;
- patients having given their written informed consent for a participation to the study and for possible genetic analysis of their personal traits.
Exclusion
- Patients under the age of 18;
- patients being under legal protection
Key Trial Info
Start Date :
February 4 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 3 2034
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT04809506
Start Date
February 4 2021
End Date
February 3 2034
Last Update
December 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Toulouse
Toulouse, France, 31059